Patents Examined by Jenny Tou
  • Patent number: 4757055
    Abstract: A process for selectively controlling or interfering with the effect or function of foreign nucleic acid in the presence of otherwise normal living cells which comprises determining the base sequence for said nucleic acid and binding the said nucleic acid with an appropriately prepared nonionic oligonucleoside alkyl or arylphosphonate analogue which is complementary to the indicated sequence of the foreign nucleic acid.
    Type: Grant
    Filed: April 27, 1984
    Date of Patent: July 12, 1988
    Assignee: The Johns Hopkins University
    Inventors: Paul S. Miller, Paul O. P. Ts'O
  • Patent number: 4754026
    Abstract: A process is disclosed for producing a 4-O-sulfonyluracil derivative of the formula ##STR1## [wherein R.sup.1 is hydrogen, halogen, alkyl and alkoxy, R.sup.2 is glycosyl having protected hydroxyls; and --SO.sub.2 R.sup.3 is an organic sulfonyl] which comprises reacting an uracil derivative of the formula ##STR2## [wherein R.sup.1 and R.sup.2 are as defined above] with an organic sulfonylating agent of the formula R.sup.3 SO.sub.2 X [wherein R.sup.3 SO.sub.2 is an organic sulfonyl and X is halogen] in the presence of potassium carbonate. The obtained 4-O-sulfonyluracil is further subjected to amination. The processes are industrially adavantageous and produce cytosine derivatives such as cytidine in high yield.
    Type: Grant
    Filed: May 27, 1986
    Date of Patent: June 28, 1988
    Assignee: Takeda Chemical Industries, Ltd.
    Inventors: Mitsuru Kawada, Kiyoharu Matsumoto, Masaaki Tsurushima
  • Patent number: 4751221
    Abstract: 2'-Deoxy-2'-fluoro-.beta.-D-arabinofuranosyl nucleosides of the following structure are disclosed: ##STR1## wherein X and Y are the same or different and are hydrogen, OR.sup.3, SR.sup.3, NR.sup.3 R.sup.4 or NHacyl wherein R.sup.3 and R.sup.4 are the same or different and are hydrogen, lower alkyl of 1 to 7 carbon atoms, aralky, or aryl;NHacyl is alkanoyl or aroylamide;R.sup.1 and R.sup.2 are the same or different and are hydrogen, acyl or aroyl.
    Type: Grant
    Filed: October 18, 1985
    Date of Patent: June 14, 1988
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Kyoichi A. Watanabe, Chung K. Chu, Jack J. Fox
  • Patent number: 4742163
    Abstract: A compound represented by the formula ##STR1## (wherein X represents a hydrogen atom or a halogen atom) provided in accordance with the invention are novel compounds of value as nonsteroidal antiinflammatory agents. Alpha-tocopherol 5-halouridine phosphoric acid diesters, in particular, are expected to be employable for antitumor agents as well.
    Type: Grant
    Filed: October 22, 1986
    Date of Patent: May 3, 1988
    Assignee: Senju Pharmaceutical Co., Ltd.
    Inventor: Kazumi Ogata
  • Patent number: 4728729
    Abstract: A novel cyanoimidazole nucleoside and derivative thereof, particularly 4-cyanoimidazolium-5-olate nucleoside and acyl derivatives thereof, and pharmaceutically acceptable salts thereof which are useful as antitumor agents and immunosuppressants, are prepared by dehydrating carboxamide derivatives of the formula: ##STR1## wherein R is an acyl group, and then, if desired, deacylating.
    Type: Grant
    Filed: March 8, 1985
    Date of Patent: March 1, 1988
    Assignee: Sumitomo Pharmaceuticals Co., Ltd.
    Inventors: Yuzo Tarumi, Toshio Atsumi, Masaru Fukui